About
Danaher Corporation (NYSE:DHR) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer
Apr 22 2026
Danaher Announces Pricing of Euro-Denominated Senior Notes Offering
Apr 21 2026
Danaher Reports First Quarter 2026 Results
Apr 15 2026
Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration
Apr 13 2026
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes
Financials
Revenue
$24.57 B
Market Cap
$135.26 B
P/E Ratio
38.00
EPS
5.03
Dividend Yield
0.67%
Translate